← Back to Search

Best Practice Alert (BPA) for Heart Failure (BETTER CARE-HF Trial)

N/A
Waitlist Available
Led By Amrita Mukhopadhyay, MD
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, 1 year
Awards & highlights

Summary

This trial tests two types of electronic reminders to help doctors prescribe the right medications for heart failure patients. The reminders are sent through best practice alerts and automated messages. The goal is to improve patient care by ensuring that doctors follow treatment guidelines.

Eligible Conditions
  • Heart Failure

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Secondary study objectives
Incidence of provider engagement with each alert type

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: In-Basket Message groupExperimental Treatment1 Intervention
Providers will receive a monthly in-basket messages linking to a list of patients who have been seen in the past 2 months or will be seen in the upcoming month with HFrEF who are not on MRA (and who do not have contraindication to MRA). This list will display each patient's current hFrEF therapies, EF, blood pressure, potassium, glomerular filtration rate, date of last visit, and date of next visit. From the list, providers can access the patient's chart, order medications, and document communication with the patient.
Group II: Best Practice Alert groupExperimental Treatment1 Intervention
Providers will receive a BPA at the time of visit for patients with HFrEF who are not on MRA (and who do not have contraindication to MRA). This alert will display the patient's current HFrEF therapies, EF, blood pressure, potassium, and glomerular filtration rate. The alert will give access to an outpatient heart failure order set, and also provide links to the most recent guidelines.
Group III: Control groupActive Control1 Intervention
Patients who will receive the current standard practice of care (no BPA or in-basket message)

Find a Location

Who is running the clinical trial?

NYU Langone HealthLead Sponsor
1,397 Previous Clinical Trials
859,631 Total Patients Enrolled
18 Trials studying Heart Failure
16,121 Patients Enrolled for Heart Failure
Amrita Mukhopadhyay, MDPrincipal InvestigatorNYU Langone Health
~663 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top